1.3 Interactions, Agonist & Isomerism Flashcards
Absorprtion
ADME
Charcoal - toxic in pos
Prokinetic - alter GIT
muscarinic - inhib emptying - oppostie
Distrib - CO increase red speec absorb
BBloq - red co sux longer NMJ
COmpeter site - enzyme syst
Phenytoin w/ sulphonamide - displace pheny
Metabolism
Ph 1 Red/ox/hydrol
Cyt p450
Inducers
Rifampicin
Inhib
Cimitideine
Excretion
Change urinary ph
Sod bic - aspirin increase
PD interactions
2 drugs @ / near site action
Direct - same mechanism
Flumazenil rev BZD
Naloxone - opiod
Indeirect - differ
neostigmine - rev NDMR - achesterase inhib
More ach at clef -compete NDMR binding site
Adrenaline - inc cAMP by GpCR
Enox - PDEi - inc CAMP
Indirect increase cAMP improve contractiliy
What is Cytp450
Family protein in Sm ER heaptocytes Mediate Red/Ox Isoform enzyme 7 most improtant in metab CYP3A4 - most
Induce cyp450
Barbiturates Phenytoin Carbamazepine griseofulvin rifampicin
Chronic alcohol
Polycyclic hrdyocarb - tobacco . meats
Brocolli - 1 form
Inhbi cyp450
Imdazole derive - keto con, itra omprea
cimetidine
etomidate -
all by bind w/ haem
Macolride Most anti dipre HIV protease inhib cyclosporine Amio
Grapefruit juice
Summation
Action drugs additive
Premed w/ bzf - then prop
Dose to achieve anaesethesia lower
Synergism
Combined action 2 drugs greater than summation
Sulphonamide & Trimethoprim
Bacteristitc alone
together bactericidal
clonidie & opiate
Potentiation
1 drugh increases effect of other
NDMR - from Mag
Isobolgram
Effeects 2 drugs
Interaction /2
Fract conc - repr x y
Draw from pg158
Affinity
How avidly a drug binds to receptor
Intrinsic activity
‘efficacy’
Magnitude of effect drug produces after bound to receptor
Potency
Measure quanitiy drug needed to produce max effect
Large dose - not potent - small dose - max effect
Compare potency two drugs
Compare EC50 or ED50
EC 50 - conc drug prod spec repsonse halfway base & max
ED50
Specific response in 50% population take
Agonist
Signifcant affinity for receptor & full intrinsic activity
Bind - receptor prod max response that capable
intrisnic activity of 1
Partial agonist
Significant affinity but only partial intrinsic activity
max response never mediate
Int act 0-1
Bupenonrphine at U rec
Can act as agonist or antag - dep sitatuion
Use alone - agonist
produce some response even if not max
Also if use along a low dose true agon
If use w/ high dose true agonist - competitive antagonist - compete for receptpr - prevent full occupancy & ergo max response
Inverse agonist
Significant affinity & intrisnce activty - opposit effect to endog agonist
Antagonist
Types
Signif affinity - no intrnisic activty
bind no response - 0
Reversible
compet or non compt
Rev comp antag compete same receprot - effect of antag overcome increase dose agonist
NDMR (nic rec NMJ) & bbloq 0 com adrenaline @ b
Rev non comp - prev activation throuhg distrortion of receptor not bind same site
Cannot overcome w/ inc conc
Kewatmine 0- glut at NMDA
Rev Comp Antag & Rev Non comp
Rev comp antag compete same receprot - effect of antag overcome increase dose agonist
NDMR (nic rec NMJ) & bbloq 0 com adrenaline @ b
Rev non comp - prev activation throuhg distrortion of receptor not bind same site
Cannot overcome w/ inc conc
Kewatmine 0- glut at NMDA
Irrev antagonist
Bind irreversibly to rec or distant site
prevent binding
The agonist dose will not overcome as it is irreversible
Pehnoxybenzamine
Alpha adreno to antagonise catetchol